Teva Pharmaceutical Industries, based in Israel, has agreed to acquire Cambridge, Mass.-based Gecko Health Innovations, a privately held company focused on developing software and product solutions to aid in compliance and adherence improvement in the management of respiratory disease.

Teva will acquire CareTRx, a novel cloud-based solution developed by Gecko Health Innovations, designed to simplify chronic respiratory disease management, connecting patients and caregivers through remote monitoring and real-time adherence tools. Together with Gecko Health Innovations founders Mark Maalouf and Dr. Yechiel Engelhard, Teva will explore innovative ways to apply the CareTRx technology to its robust pipeline and portfolio of respiratory products with the goal of enhancing clinical outcomes for patients.

CareTRx is a solution comprised of a hardware device that attaches to most metered-dose inhalers (MDIs) as well as a software program, which synchronizes and stores data through an app-based user interface.